| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.49 | 0.002 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.43 | 0.0003 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.37 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.37 | 0.01 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.35 | 0.1 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.34 | 0.1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.34 | 0.2 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.32 | 0.1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.32 | 0.02 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.3 | 1e-16 |